Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 373.00 | |
5 mg | In stock | $ 896.00 | |
10 mg | In stock | $ 1,230.00 | |
25 mg | In stock | $ 1,880.00 | |
50 mg | In stock | $ 2,580.00 | |
100 mg | In stock | $ 3,400.00 |
Description | Taprizosin(UK-338003) is a selective and orally active α1-adrenoceptor antagonist for vasodilatation in the treatment of benign prostatic hyperplasia. |
Synonyms | Taprizosin Mesylate, UK-338003, UK-338,003, UK338003, UK 338003 |
Molecular Weight | 506.58 |
Formula | C25H26N6O4S |
CAS No. | 210538-44-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Taprizosin 210538-44-6 GPCR/G Protein Neuroscience Adrenergic Receptor Taprizosin Mesylate UK-338003 UK-338,003 UK338003 UK 338003 inhibitor inhibit